» Articles » PMID: 34376220

The GoodHope Ehlers Danlos Syndrome Clinic: Development and Implementation of the First Interdisciplinary Program for Multi-system Issues in Connective Tissue Disorders at the Toronto General Hospital

Abstract

Ehlers-Danlos Syndrome (EDS) are a heterogeneous group of genetic connective tissue disorders, and typically manifests as weak joints that subluxate/dislocate, stretchy and/or fragile skin, organ/systems dysfunction, and significant widespread pain. Historically, this syndrome has been poorly understood and often overlooked. As a result, people living with EDS had difficulty obtaining an accurate diagnosis and appropriate treatment, leading to untold personal suffering as well as ineffective health care utilization. The GoodHope EDS clinic addresses systemic gaps in the diagnosis and treatment of EDS. This paper describes a leap forward-from lack of awareness, diagnosis, and treatment-to expert care that is tailored to meet the specific needs of patients with EDS. The GoodHope EDS clinic consists of experts from various medical specialties who work together to provide comprehensive care that addresses the multi-systemic nature of the syndrome. In addition, EDS-specific self-management programs have been developed that draw on exercise science, rehabilitation, and health psychology to improve physical and psychosocial wellbeing and overall quality of life. Embedded into the program are research initiatives to shed light on the clinical presentation, underlying mechanisms of pathophysiology, and syndrome management. We also lead regular educational activities for community health care providers to increase awareness and competence in the interprofessional management of EDS beyond our doors and throughout the province and country.

Citing Articles

Rates of mental health concerns among individuals assessed at the GoodHope Ehlers-Danlos Syndrome Clinic.

Slepian P, Axenova K, McCarthy M, Siegal R, Gobin K, Weinrib A Orphanet J Rare Dis. 2025; 20(1):75.

PMID: 39953579 PMC: 11829448. DOI: 10.1186/s13023-025-03550-5.


The need for primary care providers in the clinical management of hypermobility spectrum disorders and ehlers-danlos syndrome: a call to action.

Black W, Black L, Goldstein-Leever A, Fox L, Pratt L, Jones J Rheumatol Int. 2024; 44(11):2273-2278.

PMID: 39110211 DOI: 10.1007/s00296-024-05676-4.


An exploration of the journey to diagnosis of Ehlers-Danlos Syndrome (EDS) for women living in Australia.

Trudgian R, Flood T PLoS One. 2024; 19(7):e0307574.

PMID: 39052631 PMC: 11271888. DOI: 10.1371/journal.pone.0307574.


Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines.

Xu K, Li G, Wu Z, Zhang T, Wu N Orphanet J Rare Dis. 2024; 19(1):194.

PMID: 38741208 PMC: 11092078. DOI: 10.1186/s13023-024-03121-0.


Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland region.

Wagner W, Doyle T, Francomano C, Knight D, Halverson C Orphanet J Rare Dis. 2024; 19(1):122.

PMID: 38486236 PMC: 10938836. DOI: 10.1186/s13023-024-03109-w.


References
1.
Reychler G, Liistro G, Pierard G, Hermanns-Le T, Manicourt D . Inspiratory muscle strength training improves lung function in patients with the hypermobile Ehlers-Danlos syndrome: A randomized controlled trial. Am J Med Genet A. 2018; 179(3):356-364. DOI: 10.1002/ajmg.a.61016. View

2.
Cazzato D, Castori M, Lombardi R, Caravello F, Bella E, Petrucci A . Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology. 2016; 87(2):155-9. PMC: 4940063. DOI: 10.1212/WNL.0000000000002847. View

3.
Corrado B, Ciardi G . Hypermobile Ehlers-Danlos syndrome and rehabilitation: taking stock of evidence based medicine: a systematic review of the literature. J Phys Ther Sci. 2018; 30(6):843-847. PMC: 6016292. DOI: 10.1589/jpts.30.847. View

4.
Berglund B, Pettersson C, Pigg M, Kristiansson P . Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): a questionnaire study. BMC Musculoskelet Disord. 2015; 16:89. PMC: 4403907. DOI: 10.1186/s12891-015-0549-7. View

5.
Pepin M, Schwarze U, Superti-Furga A, Byers P . Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000; 342(10):673-80. DOI: 10.1056/NEJM200003093421001. View